This inventor holds 2 USPTO granted patents. Top assignee: Activaero Gmbh Research & Development. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Bernard Muellinger: Innovator in Respiratory Treatment
Introduction
Bernard Muellinger is a notable inventor based in Munich, Germany. He has made significant contributions to the field of respiratory treatment, particularly in the development of innovative inhalation systems. With a total of 2 patents, his work focuses on improving the delivery of corticosteroids for patients suffering from severe asthma.
Latest Patents
Muellinger's latest patents include a groundbreaking system for flow and volume regulated inhalation aimed at treating severe oral corticosteroid-dependent asthma. This drug and device combination system is designed to assist patients who require treatment with orally administered steroids. The method allows for the administration of inhalable corticosteroids through a regulated flow rate and volume, ensuring effective delivery into the small airways of the lungs. Additionally, he has developed a method that utilizes a glucocorticoid composition for treating severe and uncontrolled asthma. This invention directs high amounts of inhaled corticosteroids to the lower lungs, significantly reducing the need for concurrently administered oral corticosteroids and minimizing corticosteroid-related adverse effects.
Career Highlights
Bernard Muellinger is currently associated with Activaero GmbH, where he works in Research & Development. His role involves the continuous innovation of respiratory treatment technologies, contributing to advancements that enhance patient care and treatment outcomes.
Collaborations
Throughout his career, Muellinger has collaborated with esteemed colleagues such as Gerhard Scheuch and Thomas Hofmann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of respiratory health.
Conclusion
Bernard Muellinger stands out as a key figure in the innovation of respiratory treatment solutions. His patents reflect a commitment to improving the lives of patients with severe asthma through advanced inhalation technologies. His work continues to pave the way for future developments in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile